Journal article · 2024 · Open access

Novel Less Toxic, Lymphoid Tissue‐Targeted Lipid Nanoparticles Containing a Vitamin B5‐Derived Ionizable Lipid for mRNA Vaccine Delivery

Soyeon Yoo, Muhammad Faisal, Seo‐Hyeon Bae, Kounghwa Youn, Hyo‐Jung Park, Sung Pil Kwon, Il Kwon Hwang, Jisun Lee, Hyeong Jun Kim, Jae‐Hwan Nam, Gyochang Keum, Eun‐Kyoung Bang

Advanced Healthcare Materials, 14(7), e2403366 · Published 6 November 2024 · DOI 10.1002/adhm.202403366

Open full textCite this paper

In brief

“Novel Less Toxic, Lymphoid Tissue‐Targeted Lipid Nanoparticles Containing a Vitamin B5‐Derived Ionizable Lipid for mRNA Vaccine Delivery” is a 2024 journal article by Soyeon Yoo and 11 co-authors, published in Advanced Healthcare Materials. OpenAlex counts 26 citations as of 18 November 2026, which puts it in the top 1% of works published in 2024 by citations. It is open access under a CC BY-NC-ND licence: the full text is free to read at Advanced Healthcare Materials.

Citations
26
Most cited in
2026 (17)
Field-weighted impact
2.52
References
38
Authors
12

Abstract

Following their approval by the Food and Drug Administration, lipid nanoparticles (LNPs) have emerged as promising tools for delivering mRNA vaccines and therapeutics. Ionizable lipids are among the essential components of LNPs, as they play crucial roles in encapsulating mRNA and facilitating its release into the cytosol. In this study, 17 innovative ionizable lipids using vitamin B5 are designed as the core structure, aiming to reduce toxicity, to maintain vaccine efficiency, and to ensure synthetic feasibility. The top-performing LNP in terms of mRNA vaccine delivery in the mouse model is LNP 5097, which is generated by incorporating ionizable lipid I97. mRNA⊂LNP 5097 demonstrates favorable structural and physicochemical properties, high mRNA transfection efficiency, and long-term stability. Moreover, mRNA⊂LNP 5097 specifically delivers the mRNA to the spleen and lymph nodes in model mice, induces balanced Th1/Th2 immune responses, and elicits the production of high levels of neutralizing antibodies with low toxicity. The findings here suggest the high utility of LNP 5097, which includes novel vitamin B5-derived ionizable lipids with reduced toxicity, in mRNA vaccine research for both infectious diseases and cancer.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Yoo, S., Faisal, M., Bae, S., Youn, K., Park, H., Kwon, S. P., Hwang, I. K., Lee, J., Kim, H. J., Nam, J., Keum, G., & Bang, E. (2024). Novel Less Toxic, Lymphoid Tissue‐Targeted Lipid Nanoparticles Containing a Vitamin B5‐Derived Ionizable Lipid for mRNA Vaccine Delivery. Advanced Healthcare Materials, 14(7), e2403366. https://doi.org/10.1002/adhm.202403366

MLA 9

Yoo, Soyeon, et al. “Novel Less Toxic, Lymphoid Tissue‐Targeted Lipid Nanoparticles Containing a Vitamin B5‐Derived Ionizable Lipid for mRNA Vaccine Delivery.” Advanced Healthcare Materials, vol. 14, no. 7, 2024, p. e2403366. https://doi.org/10.1002/adhm.202403366.

Chicago

Yoo, Soyeon, Muhammad Faisal, Seo‐Hyeon Bae, Kounghwa Youn, Hyo‐Jung Park, Sung Pil Kwon, Il Kwon Hwang, et al. 2024. “Novel Less Toxic, Lymphoid Tissue‐Targeted Lipid Nanoparticles Containing a Vitamin B5‐Derived Ionizable Lipid for mRNA Vaccine Delivery.” Advanced Healthcare Materials 14 (7): e2403366. https://doi.org/10.1002/adhm.202403366.

Harvard

Yoo, S. et al. (2024) ‘Novel Less Toxic, Lymphoid Tissue‐Targeted Lipid Nanoparticles Containing a Vitamin B5‐Derived Ionizable Lipid for mRNA Vaccine Delivery’, Advanced Healthcare Materials, 14(7), p. e2403366. doi:10.1002/adhm.202403366.

IEEE

S. Yoo et al., “Novel Less Toxic, Lymphoid Tissue‐Targeted Lipid Nanoparticles Containing a Vitamin B5‐Derived Ionizable Lipid for mRNA Vaccine Delivery,” Advanced Healthcare Materials, vol. 14, no. 7, p. e2403366, 2024, doi: 10.1002/adhm.202403366.

BibTeX

@article{yoo2024novel,
  title     = {{Novel Less Toxic, Lymphoid Tissue‐Targeted Lipid Nanoparticles Containing a Vitamin B5‐Derived Ionizable Lipid for mRNA Vaccine Delivery}},
  author    = {Yoo, Soyeon and Faisal, Muhammad and Bae, Seo‐Hyeon and Youn, Kounghwa and Park, Hyo‐Jung and Kwon, Sung Pil and Hwang, Il Kwon and Lee, Jisun and Kim, Hyeong Jun and Nam, Jae‐Hwan and Keum, Gyochang and Bang, Eun‐Kyoung},
  journal   = {Advanced Healthcare Materials},
  year      = {2024},
  volume    = {14},
  number    = {7},
  pages     = {e2403366},
  doi       = {10.1002/adhm.202403366},
  url       = {https://doi.org/10.1002/adhm.202403366}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Topic and keywords

Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery

  • lipid nanoparticles
  • ionizable lipids
  • pantothenic acid
  • mRNA vaccine delivery
  • nanoparticle toxicity reduction
  • Th1/Th2 balance
  • neutralizing antibodies

Work with this paper

Most-cited papers in Biochemistry, Genetics and Molecular Biology

All highly cited Biochemistry, Genetics and Molecular Biology papers

Questions about this paper

How do I cite this paper in APA style?

Yoo, S., Faisal, M., Bae, S., Youn, K., Park, H., Kwon, S. P., Hwang, I. K., Lee, J., Kim, H. J., Nam, J., Keum, G., & Bang, E. (2024). Novel Less Toxic, Lymphoid Tissue‐Targeted Lipid Nanoparticles Containing a Vitamin B5‐Derived Ionizable Lipid for mRNA Vaccine Delivery. Advanced Healthcare Materials, 14(7), e2403366. https://doi.org/10.1002/adhm.202403366

How many times has this paper been cited?

26 times, according to OpenAlex on 18 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

Yes. It is open access at Advanced Healthcare Materials: sign in and open the full text from this page.

Who wrote this paper?

Soyeon Yoo, Muhammad Faisal, Seo‐Hyeon Bae, Kounghwa Youn, Hyo‐Jung Park, Sung Pil Kwon, Il Kwon Hwang, Jisun Lee, Hyeong Jun Kim, Jae‐Hwan Nam, Gyochang Keum, Eun‐Kyoung Bang.

What is the DOI of this paper?

10.1002/adhm.202403366, permanently at https://doi.org/10.1002/adhm.202403366. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 18 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.